Compound class:
Synthetic organic
|
|
References |
1. Wang Y, Wang M, Ma L, Zhang Y, Jiao Y, Zhang S, Yang Y, Li J, Wei M, Cao S et al.. (2025)
Identification of a Potent and Selective CDK9 Degrader as a Targeted Therapeutic Option for the Treatment of Small-Cell Lung Cancer. J Med Chem, 68 (3): 2528-2550. [PMID:39895086] |